Carboplatin Market, By Indication (Ovarian cancer, Small cell lung cancer and Others) and by Region (North America, Europe, Asia Pacific and RoW) ? Analysis, Share, Trends, Size, & Forecast From 2017 ? 2028
Market Executive Summary
REPORT HIGHLIGHT
The carboplatin market is estimated to represent a global market of USD xx billion by 2017 with growth rate of xx%.
Carboplatin is used in treatment of ovarian cancer as well as many other cancers such as small cell lung cancer, breast cancer, germ cell tumours. During the treatment, in some cases the cancer becomes resistant to carboplatin and other platinum based drugs such as Cis Platin. This condition is known as platinum resistant cancer. Pipeline studies are being conducted in which other drugs are used to bring back sensitivity of cancer to platinum based drugs.
Indication Takeaway
Ovarian cancer dominates the global carboplatin market over the forecast period. Increase in reoccurrence rate of ovarian cancer is expected to boost the market for carboplatin, as many medical practitioners preferred chemo therapy over surgery and radiation therapy. Furthermore, carboplatin more tolerable in geriatric patients compared to its counterpart and is more effective than carboplatin which in turn may increase the market for carboplatin in the study period. Increasing use of carboplatin to treat other form of cancer such as breast and lung is expected to propel the market for carboplatin in near future.
Regional Takeaway
In terms of revenue, Asia Pacific held the larger market share in 2017. Increasing incidence of cancer, increase in healthcare spending and growing contract manufacturing service in the region owing to low cost of manufacturing are the main factor driving the growth of carboplatin market over the forecast period. Moreover, presence of favorable government initiatives and increase in contract research and development service in China and India is expected to boost the market for carboplatin in the region.
Key Vendor Takeaway
Johnson Metthey
Heraeus Group
Tecoland Corporation
Qilu Pharmaceutical Company
Mylan, Inc.
Taj Pharmaceuticals
Umicore
Teva Pharmaceutical
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year ? 2017 ? 2021
Base Year ? 2021
Estimated Year ? 2022
Projected Year ? 2028
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY INDICATION
Ovarian cancer
Small cell lung cancer
Others
MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America
Table of Contents
TABLE OF CONTENT
1. CARBOPLATIN MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. CARBOPLATIN KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CARBOPLATIN INDUSTRY STUDY
4.1. Porter?s Analysis
4.2. Market Attractiveness Analysis
4.3. Raw Material Analysis
4.3.1. Wheat
4.3.2. Potato
4.3.3. Corn
4.3.4. Cassava
4.4. Technology Overview
4.5. Regulatory Framework Analysis
5. CARBOPLATIN MARKET LANDSCAPE
5.1. Market Share Analysis
6. CARBOPLATIN MARKET ? BY INDICATION
6.1. Overview
6.1.1. Overview
6.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
6.2. Ovarian cancer
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
6.3. Small cell lung cancer
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
6.4. Others
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7. CARBOPLATIN MARKET? BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.2.3. U.S.
7.2.3.1. Overview
7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.2.4. Canada
7.2.4.1. Overview
7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.3. Europe
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.3.3. France
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.3.4. Germany
7.3.4.1. Overview
7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.3.5. Rest of Europe
7.3.5.1. Overview
7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.4. Asia Pacific (APAC)
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.4.3. China
7.4.3.1. Overview
7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.4.4. India
7.4.4.1. Overview
7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.4.5. Rest of APAC
7.4.5.1. Overview
7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.5. Rest of the World
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.5.3. Latin America
7.5.3.1. Overview
7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
7.5.4. Middle East and Africa
7.5.4.1. Overview
7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 ? 2028, (US$ Billion)
8. KEY VENDOR ANALYSIS
8.1. Johnson Metthey
8.1.1. Company Overview
8.1.2. SWOT Analysis
8.1.3. Key Developments
8.2. Heraeus Group
8.2.1. Company Overview
8.2.2. SWOT Analysis
8.2.3. Key Developments
8.3. Tecoland Corporation
8.3.1. Company Overview
8.3.2. SWOT Analysis
8.3.3. Key Developments
8.4. Qilu Pharmaceutical Company
8.4.1. Company Overview
8.4.2. SWOT Analysis
8.4.3. Key Developments
8.5. Mylan
8.5.1. Company Overview
8.5.2. SWOT Analysis
8.5.3. Key Developments
8.6. Taj Pharmaceuticals
8.6.1. Company Overview
8.6.2. SWOT Analysis
8.6.3. Key Developments
8.7. Umicore
8.7.1. Company Overview
8.7.2. SWOT Analysis
8.7.3. Key Developments
8.8. Teva Pharmaceutical
8.8.1. Company Overview
8.8.2. SWOT Analysis
8.8.3. Key Developments
9. 360 DEGREE ANALYSTVIEW
10. APPENDIX
10.1. Research Methodology
10.2. Abbreviations
10.3. Disclaimer
10.4. Contact Us
List of Figures
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2017-2028 (Value %)
Figure 4 Value Chain Analysis
Figure 5 Carboplatin Market, by Indication, 2017 ? 2028 (USD Billion)
Figure 6 Carboplatin Market, by Geography, 2017 ? 2028 (USD Billion)
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
